Gentera Biotechnology Limited Company was founded in Istanbul in 2013 with the support of TÜBİTAK 1512. Our team consists of expert molecular biologists and geneticists, clinicians computer scientists and statisticians.
Developed by Gentera in 2015, GDPE is able to fully automate all operations from data transfer to analysis on NGS platforms. With this user-friendly interface, this system which dedicates human error to data analysis, has been established in different centers providing routine diagnostic services.
As a result of our R&D studies, our NGS kits that we have developed for use in the genetic diagnosis of the 500 most common hereditary diseases are ready for routine applications. With the use of multiplex NGS kits for diagnosing common hereditary diseases, genetic testing costs and time have been greatly reduced.
Our service network starting with Primer Design and Synthesis is shaped according to your requests until Bioinformatics Analyzes after NGS and Microarray analyzes.